2021年肝癌治疗进展  

Year-end review of liver cancer treatment in 2021

作　　者：曾慧岚 陈敏山[1] Zeng Huilan;Chen Minshan(Department of Liver Surgery,Sun Yat-sen University Cancer Center,Guangzhou 510060,China)

机构地区：[1]中山大学肿瘤防治中心肝脏外科,广州510060

出　　处：《肿瘤综合治疗电子杂志》2022年第1期72-77,共6页Journal of Multidisciplinary Cancer Management(Electronic Version)

摘　　要：我国肝癌的发病率和病死率仍居高不下。包括手术、消融、放疗、介入、靶向、免疫治疗等有机结合的多学科综合治疗模式能有效改善患者预后,并已获得专家共识。本文将从肝细胞癌的局部治疗、全身治疗和肝胆管细胞癌的综合治疗三个方面系统总结2021年肝癌研究进展。The morbidity and mortality of liver cancer in China are still high.Multidisciplinary comprehensive treatment mode,including surgery,ablation,radiotherapy,intervention,targeting and immunotherapy,can effectively improve the prognosis of patients,which has been recognized by experts.This article will systematically summarize the research progress in 2021 from three aspects:local treatment and systemic treatment of hepatocellular carcinoma,comprehensive treatment of intrahepatic cholangiocarcinoma.

关 键 词：肝细胞癌 肝胆管细胞癌 多学科综合治疗 靶向治疗 免疫治疗 

分 类 号：R735.7[医药卫生—肿瘤]